Purpose: To report peculiar clinical findings in young choroideremia (CHM) patients. Methods: We retrospectively reviewed young (age <20 years at the first evaluation) CHM patients examined at the Regional Reference Center for Hereditary Retinal Degenerations at the Eye Clinic in Florence between 2012 and 2018. We took into consideration patients with ophthalmological examinations, fundus color photographs, fundus autofluorescence (FAF) images, optical coherence tomography (OCT) scans, full-field electroretinograms, and Goldmann visual fields. Results: In our series, we studied 8 young CHM patients (average age 13.8 years, median age 12.5, range 10–20) for a total of 16 eyes. Visual acuity (VA) was 20/20 in 7 patients and 20/25 in both eyes of 1 patient. We identified a peculiar central FAF pattern (detectable in 3 patients), characterized by reduced central hypo-autofluorescence. Long OCT scans showed different forms of parapapillary retinal involvement from the mildest to the most severe form when the macula is still preserved. In 3 patients, at the time of atrophic changes at the posterior pole, it was possible to detect a progressive reduction of foveal pigmentation during follow-up. We found mutations of the CHM gene in all 6 patients who had been screened. Conclusions: CHM is a progressive retinal disorder which involves both the peripheral and the central retina. Using a multimodal imaging approach, we described peculiar central abnormalities underlying the early involvement of the central retina in young CHM patients with a good VA.

1.
Coussa
RG
,
Traboulsi
EI
.
Choroideremia: a review of general findings and pathogenesis
.
Ophthalmic Genet
.
2012
Jun
;
33
(
2
):
57
65
.
[PubMed]
1381-6810
2.
van den Hurk
JA
,
Schwartz
M
,
van Bokhoven
H
,
van de Pol
TJ
,
Bogerd
L
,
Pinckers
AJ
, et al
Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene
.
Hum Mutat
.
1997
;
9
(
2
):
110
7
.
[PubMed]
1059-7794
3.
Khan
KN
,
Islam
F
,
Moore
AT
,
Michaelides
M
.
Clinical and Genetic Features of Choroideremia in Childhood
.
Ophthalmology
.
2016
Oct
;
123
(
10
):
2158
65
.
[PubMed]
0161-6420
4.
Aleman
TS
,
Han
G
,
Serrano
LW
,
Fuerst
NM
,
Charlson
ES
,
Pearson
DJ
, et al
Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study
.
Ophthalmology
.
2017
Mar
;
124
(
3
):
359
73
.
[PubMed]
0161-6420
5.
Duncan
JL
,
Aleman
TS
,
Gardner
LM
,
De Castro
E
,
Marks
DA
,
Emmons
JM
, et al
Macular pigment and lutein supplementation in choroideremia
.
Exp Eye Res
.
2002
Mar
;
74
(
3
):
371
81
.
[PubMed]
0014-4835
6.
Jacobson
SG
,
Cideciyan
AV
,
Sumaroka
A
,
Aleman
TS
,
Schwartz
SB
,
Windsor
EA
, et al
Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations
.
Invest Ophthalmol Vis Sci
.
2006
Sep
;
47
(
9
):
4113
20
.
[PubMed]
0146-0404
7.
Nabholz
N
,
Lorenzini
MC
,
Bocquet
B
, et al
Clinical Evaluation and Cone Alterations in Choroideremia. Ophthalmology. 2016 Aug;123(8) 1830-1832.McCulloch C. Choroideremia: a clinical and pathologic review
.
Trans Am Ophthalmol Soc
.
1969
;
67
:
142
95
.0065-9533
8.
Heon
E
,
Alabduljalil
T
,
McGuigan
DB
 3rd
,
Cideciyan
AV
,
Li
S
,
Chen
S
, et al
Visual Function and Central Retinal Structure in Choroideremia
.
Invest Ophthalmol Vis Sci
.
2016
Jul
;
57
(
9
):
OCT377
87
.
[PubMed]
0146-0404
9.
Murro
V
,
Mucciolo
DP
,
Passerini
I
,
Palchetti
S
,
Sodi
A
,
Virgili
G
, et al
Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers
.
Graefes Arch Clin Exp Ophthalmol
.
2017
Nov
;
255
(
11
):
2099
111
.
[PubMed]
0721-832X
10.
Forsius
H
,
Hyvärinen
L
,
Nieminen
H
,
Flower
R
.
Fluorescein and indocyanine green fluorescence angiography in study of affected males and in female carriers with choroidermia. A preliminary report
.
Acta Ophthalmol (Copenh)
.
1977
Jun
;
55
(
3
):
459
70
.
[PubMed]
0001-639X
11.
Syed
R
,
Sundquist
SM
,
Ratnam
K
, et al
High-resolution images of retinal structure in patients with choroideremia.
Invest Ophthalmol Vis Sci
2013
, 1;54(2):950-61.
12.
Lee
MY
,
Ham
DI
.
Subretinal drusenoid deposits with increased autofluorescence in eyes with reticular pseudodrusen
.
Retina
.
2014
Jan
;
34
(
1
):
69
76
.
[PubMed]
0275-004X
13.
Goldberg
NR
,
Greenberg
JP
,
Laud
K
,
Tsang
S
,
Freund
KB
.
Outer retinal tubulation in degenerative retinal disorders
.
Retina
.
2013
Oct
;
33
(
9
):
1871
6
.
[PubMed]
0275-004X
14.
King
BJ
,
Sapoznik
KA
,
Elsner
AE
,
Gast
TJ
,
Papay
JA
,
Clark
CA
, et al
SD-OCT and Adaptive Optics Imaging of Outer Retinal Tubulation
.
Optom Vis Sci
.
2017
Mar
;
94
(
3
):
411
22
.
[PubMed]
1040-5488
15.
Zweifel
SA
,
Engelbert
M
,
Laud
K
,
Margolis
R
,
Spaide
RF
,
Freund
KB
.
Outer retinal tubulation: a novel optical coherence tomography finding
.
Arch Ophthalmol
.
2009
Dec
;
127
(
12
):
1596
602
.
[PubMed]
0003-9950
16.
Dolz-Marco
R
,
Litts
KM
,
Tan
AC
,
Freund
KB
,
Curcio
CA
.
The Evolution of Outer Retinal Tubulation, a Neurodegeneration and Gliosis Prominent in Macular Diseases
.
Ophthalmology
.
2017
Sep
;
124
(
9
):
1353
67
.
[PubMed]
0161-6420
17.
Preti
RC
,
Govetto
A
,
Filho
RG
,
Cabral Zacharias
L
,
Gianotti Pimentel
S
,
Takahashi
WY
, et al
OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF OUTER RETINAL TUBULATIONS: Sequential Evolution and Pathophysiological Insights
.
Retina
.
2018
Aug
;
38
(
8
):
1518
25
.
[PubMed]
0275-004X
18.
Jolly
JK
,
Edwards
TL
,
Moules
J
,
Groppe
M
,
Downes
SM
,
MacLaren
RE
.
A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia
.
Invest Ophthalmol Vis Sci
.
2016
Aug
;
57
(
10
):
4498
503
.
[PubMed]
0146-0404
19.
Jolly
JK
,
Xue
K
,
Edwards
TL
,
Groppe
M
,
MacLaren
RE
.
Characterizing the Natural History of Visual Function in Choroideremia Using Microperimetry and Multimodal Retinal Imaging
.
Invest Ophthalmol Vis Sci
.
2017
Oct
;
58
(
12
):
5575
83
.
[PubMed]
0146-0404
20.
Aylward
JW
,
Xue
K
,
Patrício
MI
, et al
Retinal Degeneration in Choroideremia follows an Exponential Decay Function.
Ophthalmology.
2018
Mar 23. pii: S0161-6420(18)30245-8.
21.
Morales
MU
,
Saker
S
,
Mehta
RL
,
Rubinstein
M
,
Amoaku
WM
.
Preferred retinal locus profile during prolonged fixation attempts
.
Can J Ophthalmol
.
2013
Oct
;
48
(
5
):
368
74
.
[PubMed]
0008-4182
22.
Yuan
A
,
Kaines
A
,
Jain
A
, et al
Ultra-wide-field and autofluorescence imaging of choroidal dystrophies.
Ophthalmic Surg Lasers Imaging.
2010
Oct 28;41 Online:e1-5.
23.
Pichi
F
,
Abboud
EB
,
Ghazi
NG
,
Khan
AO
.
Fundus autofluorescence imaging in hereditary retinal diseases
.
Acta Ophthalmol
.
2017
Nov
.
[PubMed]
1755-375X
24.
Pfau
M
,
Goerdt
L
,
Schmitz-Valckenberg
S
,
Mauschitz
MM
,
Mishra
DK
,
Holz
FG
, et al
Green-Light Autofluorescence Versus Combined Blue-Light Autofluorescence and Near-Infrared Reflectance Imaging in Geographic Atrophy Secondary to Age-Related Macular Degeneration
.
Invest Ophthalmol Vis Sci
.
2017
May
;
58
(
6
):
BIO121
30
.
[PubMed]
0146-0404
25.
Murakami
T
,
Akimoto
M
,
Ooto
S
,
Suzuki
T
,
Ikeda
H
,
Kawagoe
N
, et al
Association between abnormal autofluorescence and photoreceptor disorganization in retinitis pigmentosa
.
Am J Ophthalmol
.
2008
Apr
;
145
(
4
):
687
94
.
[PubMed]
0002-9394
26.
Yung
M
,
Klufas
MA
,
Sarraf
D
.
Clinical applications of fundus autofluorescence in retinal disease
.
Int J Retina Vitreous
.
2016
Apr
;
2
(
1
):
12
.
[PubMed]
2056-9920
27.
Morgan
JI
,
Han
G
,
Klinman
E
,
Maguire
WM
,
Chung
DC
,
Maguire
AM
, et al
High-resolution adaptive optics retinal imaging of cellular structure in choroideremia
.
Invest Ophthalmol Vis Sci
.
2014
Sep
;
55
(
10
):
6381
97
.
[PubMed]
0146-0404
28.
Tolmachova
T
,
Anders
R
,
Abrink
M
,
Bugeon
L
,
Dallman
MJ
,
Futter
CE
, et al
Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia
.
J Clin Invest
.
2006
Feb
;
116
(
2
):
386
94
.
[PubMed]
0021-9738
29.
Hariri
AH
,
Velaga
SB
,
Girach
A
,
Ip
MS
,
Le
PV
,
Lam
BL
, et al;
Natural History of the Progression of Choroideremia (NIGHT) Study Group
.
Measurement and Reproducibility of Preserved Ellipsoid Zone Area and Preserved Retinal Pigment Epithelium Area in Eyes With Choroideremia
.
Am J Ophthalmol
.
2017
Jul
;
179
:
110
7
.
[PubMed]
0002-9394
30.
Dysli
C
,
Wolf
S
,
Tran
HV
,
Zinkernagel
MS
.
Autofluorescence Lifetimes in Patients With Choroideremia Identify Photoreceptors in Areas With Retinal Pigment Epithelium Atrophy
.
Invest Ophthalmol Vis Sci
.
2016
Dec
;
57
(
15
):
6714
21
.
[PubMed]
0146-0404
31.
Sun
LW
,
Johnson
RD
,
Williams
V
, et al
Multimodal Imaging of Photoreceptor Structure in Choroideremia. PLoS One
2016
, 9;11(12):e0167526.
32.
Xue
K
,
Oldani
M
,
Jolly
JK
, et al
Correlation of Optical Coherence Tomography and Autofluorescence in the Outer Retina and Choroid of Patients With Choroideremia.
Invest Ophthalmol Vis Sci
2016
1;57(8):3674-84.
33.
Tolmachova
T
,
Wavre-Shapton
ST
,
Barnard
AR
,
MacLaren
RE
,
Futter
CE
,
Seabra
MC
.
Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia
.
Invest Ophthalmol Vis Sci
.
2010
Oct
;
51
(
10
):
4913
20
.
[PubMed]
0146-0404
34.
Krock
BL
,
Bilotta
J
,
Perkins
BD
.
Noncell-autonomous photoreceptor degeneration in a zebrafish model of choroideremia
.
Proc Natl Acad Sci USA
.
2007
Mar
;
104
(
11
):
4600
5
.
[PubMed]
0027-8424
35.
Dimopoulos
IS
,
Chan
S
,
MacLaren
RE
,
MacDonald
IM
.
Pathogenic mechanisms and the prospect of gene therapy for choroideremia
.
Expert Opin Orphan Drugs
.
2015
Jul
;
3
(
7
):
787
98
.
[PubMed]
2167-8707
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.